Prudential Financial Inc Durect Corp Transaction History

Prudential Financial Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.38 - $0.64 $5,608 - $9,446	-14,760 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$0.9 - $1.31 $18,543 - $26,991	-20,604 Reduced 58.26%	14,760 $14,000
Q3 2021 Nov 15, 2021	BUY	$1.21 - $1.61 $23,484 - $31,248	19,409 Added 121.65%	35,364 $45,000
Q2 2021 Aug 16, 2021	SELL	$1.6 - $2.02 $16,769 - $21,171	-10,481 Reduced 39.65%	15,955 $26,000
Q1 2021 May 12, 2021	BUY	$1.86 - $2.87 $2,641 - $4,075	1,420 Added 5.68%	26,436 $52,000
Q4 2020 Feb 16, 2021	SELL	$1.65 - $2.43 $825 - $1,215	-500 Reduced 1.96%	25,016 $52,000
Q3 2020 Nov 16, 2020	SELL	$1.6 - $2.35 $203 - $298	-127 Reduced 0.5%	25,516 $44,000
Q2 2020 Aug 12, 2020	SELL	$1.33 - $2.76 $2,528 - $5,246	-1,901 Reduced 6.9%	25,643 $59,000
Q2 2019 Aug 08, 2019	SELL	$0.51 - $0.86 $3,814 - $6,432	-7,480 Reduced 21.36%	27,544 $0
Q1 2019 May 15, 2019	SELL	$0.51 - $0.82 $27,762 - $44,637	-54,436 Reduced 60.85%	35,024 $0
Q4 2018 Feb 07, 2019	BUY	$0.48 - $1.1 $36,249 - $83,072	75,520 Added 541.75%	89,460 $42,000
Q4 2017 Feb 13, 2018	BUY	$0.78 - $2.1 $530 - $1,428	680 Added 5.13%	13,940 $13,000
Q3 2017 Nov 02, 2017	BUY	$1.55 - $1.82 $20,553 - $24,133	13,260	13,260 $23,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $180M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.